Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takeshi Kuwata
Observed name:
T. Kuwata
Institution:
National Cancer Center Hospital East
Observed institution:
National Cancer Center Hospital East
ORCID:
0000-0003-0044-953X
Observed ORCID:
0000-0003-0044-953X
OpenAlex ID:
A5121025005
Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI)
2026
·
Taro Shibuki
, Riu Yamashita
, et al.
·
International Journal of Clinical Oncology
·
8
PDF
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing–Based Assays With Immunohistochemistry
2026
·
Michiko Nagamine
, Takao Fujisawa
, et al.
·
JCO Precision Oncology
·
4
PDF
Psychological distress and cancer worry in unaffected relatives undergoing cascade testing with multigene panel testing
2026
·
Kaori Kimura
, Takeshi Kuwata
, et al.
·
Journal of Human Genetics
·
2
PDF
Pathologic determinants of ctDNA-shedding in colorectal cancer metastases.
2026
·
Hiroki Yukami
, Hideaki Bando
, et al.
·
Journal of Clinical Oncology
·
1
817TiP Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI)
2025
·
T. Shibuki
, R. Yamashita
, et al.
·
Annals of Oncology
·
1
Gastric cancer biomarker testing in Japan: a second nationwide survey of testing practices and associations with testing location
2026
·
Amane Yamamoto
, Takeshi Kuwata
, et al.
·
Gastric Cancer
Thoracic recurrence after complete gross resection in advanced ovarian cancer: The clinical impact of occult subdiaphragmatic lymphatic invasion
2026
·
Junki Onishi
, Michiko Nagamine
, et al.
·
Gynecologic Oncology
Japanese Society for Hereditary Tumors Guidance: Hereditary Cancer Syndromes With Multigene Panel Testing, 2025 Edition
2026
·
Reiko Yoshida
, Akira Hirasawa
, et al.
·
Cancer Science
PDF
Multigene panel testing for hereditary tumor syndromes: an engine for stratified, preemptive cancer medicine in Japan
2026
·
Akira Hirasawa
, Reiko Yoshida
, et al.
·
International Journal of Clinical Oncology
PDF
Molecular residual disease detection for ovarian cancer using a WGS-based ctDNA assay: Initial findings from the MONSTAR-SCREEN-3.
2026
·
Fuminori Ito
, Hiroshi Tanabe
, et al.
·
Journal of Clinical Oncology
Hepatic‐Differentiated Subpopulation in Clear Cell Renal Cell Carcinoma: A Multi‐Omics Analysis of Tumors With Lymphovascular Invasion
2026
·
Shugo Yajima
, Yuichiro Tsukada
, et al.
·
Cancer Medicine
Abstract PS2-09-07: Ultra-sensitive Molecular Residual Disease Detection in Breast Cancer Using Whole-Genome Sequencing-Based Personalized ctDNA Panels: Preliminary Results from the MONSTAR-SCREEN-3 Project
2026
·
Y. Naito
, M. Nishimura
, et al.
·
Clinical Cancer Research
Comprehensive whole-genome analysis of colorectal cancer (CONDUCTOR study): Integrating RAS/BRAF, MSI status, and intron–exon alterations.
2026
·
Hideaki Bando
, Koji Ando
, et al.
·
Journal of Clinical Oncology
PDF
816TiP Integrative spatiotemporal multi-omics and single-cell analysis of circulating tumor cells (MONSTAR-CTC): a substudy of MONSTAR-SCREEN-3
2025
·
T. Hashimoto
, T. Shibuki
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
14
Citation count:
16
H-index:
2
I10-index:
Year
Topic
Type